# CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

> **NCT04684641** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 8 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Standard Dose YPT-01
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04684641
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-29
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-06-22
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684641, "CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04684641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*